B. Robinson

K. Lynn, M. Currie, B. Robinson, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Characterisation of enzyme prodrug gene therapy combinations in coated spheroids and vascular networks in vitro

M. Currie, G. Dachs, Dan Li, 2012, The journal of gene medicine.

Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer

M. Currie, G. Dachs, B. Robinson, 2010, British Journal of Cancer.

Cytokeratin KRT8/18 expression differentiates distinct subtypes of grade 3 invasive ductal carcinoma of the breast.

C. Morris, L. Walker, G. Harris, 2007, Cancer genetics and cytogenetics.

The angiogenic switch for vascular endothelial growth factor (VEGF)‐A, VEGF‐B, VEGF‐C, and VEGF‐D in the adenoma–carcinoma sequence during colorectal cancer progression

Stephen B Fox, M. Currie, B. Robinson, 2003, The Journal of pathology.

Dual-Color Fluorescence In Situ Hybridization Reveals an Association of Chromosome 8q22 but Not 8p21 Imbalance with High Grade Invasive Breast Carcinoma

C. Morris, M. McDonald, L. Walker, 2013, PloS one.

Breast cancer and cytomegalovirus

J. Potter, H. Rollag, L. Walker, 2019, Clinical and Translational Oncology.

The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers.

S. Fox, A. Harris, Cheng Han, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.

B. Hock, J. McKenzie, M. Currie, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cytomegalovirus and Epstein-Barr Virus in Breast Cancer

J. Potter, L. Walker, J. Pearson, 2015, PloS one.

Investigation of Experimental Factors That Underlie BRCA1/2 mRNA Isoform Expression Variation: Recommendations for Utilizing Targeted RNA Sequencing to Evaluate Potential Spliceogenic Variants

A. Spurdle, L. Walker, J. Pearson, 2018, Front. Oncol..

Vitamin C Administration by Intravenous Infusion Increases Tumor Ascorbate Content in Patients With Colon Cancer: A Clinical Intervention Study

A. Carr, J. Pullar, G. Dachs, 2020, Frontiers in Oncology.

The Effect of Dihydropyrimidine Dehydrogenase Deficiency on Outcomes with Fluorouracil

E. Begg, B. Robinson, S. Gardiner, 2002, Adverse drug reactions and toxicological reviews.

Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients

A. Spurdle, L. Walker, C. Lintott, 2020, Breast Cancer Research and Treatment.

Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas.

S. Fox, C. Frampton, M. Currie, 2004, Journal of clinical pathology.

A profile of prognostic and molecular factors in European and Māori breast cancer patients

C. Frampton, G. Harris, M. Currie, 2010, BMC Cancer.

Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.

M. Büchler, J. Neoptolemos, J. Izbicki, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of serum inflammatory cytokines on cytochrome P450 drug metabolising activity during breast cancer chemotherapy: a patient feasibility study

M. Doogue, M. Strother, M. Currie, 2021, Scientific Reports.

Increased Ascorbate Content of Glioblastoma Is Associated With a Suppressed Hypoxic Response and Improved Patient Survival

Tania L. Slatter, J. Royds, G. Dachs, 2022, Frontiers in Oncology.

Effect of post-implant exercise on tumour growth rate, perfusion and hypoxia in mice

B. Hock, M. Currie, G. Dachs, 2020, PloS one.

Effects of Exercise and Anti-PD-1 on the Tumour Microenvironment.

B. Hock, M. Currie, G. Dachs, 2021, Immunology letters.

Circadian pharmacokinetics of methotrexate

E. Begg, B. Robinson, G. Jeffery, 2004, Cancer Chemotherapy and Pharmacology.

Limited Association Between Ascorbate Concentrations and Vitamin C Transporters in Renal Cell Carcinoma Cells and Clinical Samples.

G. Dachs, B. Robinson, C. Wohlrab, 2021, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

Cancer disparities in indigenous Polynesian populations: Māori, Native Hawaiians, and Pacific people.

L. Le Marchand, M. Jeffreys, M. Currie, 2008, The Lancet. Oncology.

Baroreflex failure secondary to paraneoplastic encephalomyelitis in a 17 year old woman with neuroblastoma

B. Robinson, C. Krediet, D. Jardine, 2004, Journal of Neurology, Neurosurgery & Psychiatry.

Quantifying BRCA1 and BRCA2 mRNA Isoform Expression Levels in Single Cells

A. Spurdle, L. Walker, J. Pearson, 2019, International journal of molecular sciences.

Frailty in Older Patients Referred to Oncology, and Impact of Treatment: Use of a Modified 6 Item Score

B. Robinson, C. Frampton, D. Harris, 2019, Clinical Oncology and Research.

Responding to Acute Care Needs of Patients With Cancer: Recent Trends Across Continents.

P. Selby, M. Krzyzanowska, F. Collinson, 2016, The oncologist.

Is the Immunogenicity of PD-1 Blocking Antibodies a Confounding Variable in Murine Studies?

B. Hock, Liping Goddard, M. Currie, 2021, Immunology letters.

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C.

R. Simes, A. Broad, V. Ganju, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized comparison of single-agent doxorubicin and epirubicin as first-line cytotoxic therapy in advanced breast cancer.

V. Harvey, C. Atkinson, P. Dady, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of xylazine in camels.

B. Robinson, P. K. Peshin, J. M. Nigam, 1980, Journal of the American Veterinary Medical Association.

Control of emesis associated with cancer chemotherapy.

B. Robinson, 1993, The New Zealand medical journal.

Epidermal growth factor (hEGF) has no effect on murine intestine epithelial damage and regeneration after melphalan.

T. Mcelwain, B. Robinson, R. Clutterbuck, 1985, British Journal of Cancer.

Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension

C. Frampton, B. Robinson, C. Frampton, 2013, Respirology.

Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel‐Lindau gene and hypoxia

A. Harris, Cheng Han, M. Currie, 2002, The Journal of pathology.

Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling.

S. Fox, A. Harris, Cheng Han, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels

G. Dachs, B. Robinson, H. Morrin, 2019, BMC Cancer.

Tumour growth in mice resistant to diet-induced obesity

M. Currie, G. Dachs, B. Robinson, 2015 .

Anti-vascular agent Combretastatin A-4-P modulates Hypoxia Inducible Factor-1 and gene expression

C. Kanthou, G. Tozer, M. Currie, 2006, BMC Cancer.

A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer

D. Goldstein, J. Zhi, E. Chen, 2011, Cancer Chemotherapy and Pharmacology.

Geriatric subgroup of AGITG MAX trial: International randomized phase III trial of capecitabine (C), bevacizumab (B), and mitomycin C (M) in first-line metastatic colorectal cancer (CRC).

J. Simes, A. Broad, V. Ganju, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Childhood pica. Some aspects of the clinical profile in Manchester, Jamaica.

B. Robinson, W. Tolan, O. Golding-Beecher, 1990, The West Indian medical journal.

Patients’ and carers’ priorities for cancer research in Aotearoa/New Zealand

J. Jordan, G. Dachs, B. Robinson, 2023, PloS one.

The Christchurch Tissue Bank to support cancer research.

S. Fox, M. Currie, G. Dachs, 2005, The New Zealand medical journal.

Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels

G. Dachs, B. Robinson, H. Morrin, 2019, BMC Cancer.

V. Gebski, P. Gibbs, V. Heinemann, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.

B. Hock, J. McKenzie, M. Currie, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.